This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,559,478,068 units of Ondansetron HCL 4 mg tablets, a medication used to treat nausea and vomiting. The firm-fixed-price contract has a ceiling value of $7,065.42 and a completion date of January 3, 2023. This delivery order is part of a larger Indefinite Delivery Contract (IDC)...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Ondansetron HCL 4 mg tablets, a medication used to treat nausea and vomiting. The contract is a firm fixed-price, non-set-aside award with a ceiling value of $1,778.38 and a period of performance through April 24, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4568135237 - Ondansetron HCL 4 mg Tablet 30s, a medication used to treat nausea and vomiting. The contract is a firm fixed-price delivery order with a ceiling value of $15,535.21 and a performance period extending through May 6, 2025. This contract is not set aside and is open to...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,567,090,414 units of Ondansetron HCL 4 mg tablets, a medication used to prevent nausea and vomiting. The contract has a ceiling value of $47,037.51 and a completion date of January 30, 2025. The contract is a firm-fixed-price delivery order, with no set-aside designation....
This is a delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the U.S. Defense Logistics Agency (DLA). The contract is for the supply of Ondansetron HCL 4 mg tablets, a medication used to treat nausea and vomiting. The contract has a ceiling value of $5,386.69 and runs through October 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, valued at up to $999,999,999,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Ondansetron HCL 4 mg tablets, a medication used to prevent nausea and vomiting. The contract has a firm fixed price of $6,065.75 and a completion date of March 31, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Ondansetron HCL 4 mg tablets, a medication used to treat nausea and vomiting. The contract has a ceiling value of $2,873.75 and a completion date of February 10, 2025. It is a firm fixed-price contract with no set-aside designation, indicating open competition. Amerisourcebergen Drug...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $4,062.35 firm fixed price contract is for the supply of 4 mg Ondansetron HCl tablets, a medication used to treat nausea and vomiting. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00, which serves as the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $23,338.60 firm fixed-price contract is for the delivery of ondansetron hydrochloride 4 mg tablets, a medication used to treat nausea and vomiting. The contract is a child award under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999, which Amerisourcebergen holds with the DLA Troop Support...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Ondansetron HCL 4 mg tablets, a medication used to treat nausea and vomiting. The contract has a Firm Fixed Price pricing type and a Ceiling Value of $17,453.56. It was awarded on April 7, 2025, with an Ultimate Completion Date of April 8, 2025. The contract is not designated as a Set-Aside. AmerisourceBergen Drug...